ARKG vs GBTC

ARK Genomic Revolution ETF vs Grayscale Bitcoin Trust

Quick take
  • • ARKG has the lower expense ratio at 0.75% vs 1.50% for GBTC.

Side-by-side metrics

MetricARKGGBTC
Expense ratio
Annual fee. Lower is better.
0.75%1.50%
Dividend yield
Trailing 12-month yield.
0.00%0.00%
AUM
Assets under management — bigger funds are typically more liquid.
$2.21B$9.62B
YTD return
66.55%-15.68%
1-year return
——
3-year return
Annualized.
——
5-year return
Annualized.
——
10-year return
Annualized.
——
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
2.110.00
P/E ratio
——
Last price
$47.17$57.41
Inception
——
Issuer
ARKGrayscale

ARKG top holdings

Top holdings · ARKG
TWSTTwist Bioscience Corp8.75%
TXG10x Genomics Inc Ordinary Shares - Class A8.73%
TEMTempus AI Inc Class A common stock8.36%
ABSIAbsci Corp5.56%
CRSPCRISPR Therapeutics AG5.22%
GHGuardant Health Inc4.88%
NTRANatera Inc4.71%
ILMNIllumina Inc4.69%
LLYEli Lilly and Co3.92%
BEAMBeam Therapeutics Inc3.69%
Sector breakdown · ARKG
Healthcare100.0%

GBTC top holdings

Holdings data unavailable for GBTC.

About ARKG

ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology. Managed by ARK, the fund carries $2.2B in assets under management, an expense ratio of 0.75%. Its largest holding is Twist Bioscience Corp (TWST), which represents 8.7% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.

About GBTC

GBTC (Grayscale Bitcoin Trust) is Spot Bitcoin ETF from Grayscale. Managed by Grayscale, the fund carries $9.6B in assets under management, an expense ratio of 1.50%.